- First clinical combination study of BBP-398 and LUMAKRAS set to evaluate safety and preliminary efficacy in solid tumors with the KRAS G12C mutation PALO ALTO, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- BridgeBio
January 9, 1:16 PM
Reviewing the list of companies that were at a new 52 week high and the ones that had hit a fresh 52 week low last week, I was struck by just how many of the companies in the 52 week high list were financial/banking companies and from the energy sector. Similarly, a large number of companies in the 52 week low list were either biotech companies or from the technology sector.
January 5, 2:26 PM
After a huge move lower, shares of BridgeBio Pharma, Inc. (NASDAQ: BBIO) looked like they were beginning to recover. But then the stock crashed into a wall of sellers around the $17 level, which has put an end to the rally.
January 2, 4:30 PM
Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year.
December 31, 5:07 AM
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
December 29, 5:06 AM
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social media post on a potential short squeeze.